Answers are grounded in this paper and cite their sources.
Large segmental bone defects are difficult to repair because endogenous stem-cell activation, vascular ingrowth, and osteogenic maturation are insufficient to rebuild organized bone tissue. Bone organoids offer a promising regenerative strategy, but current systems are limited by Matrigel dependence, poor vascularization, low post-implantation survival, and inadequate reconstruction of hierarchical bone microarchitecture. Here, we report a development-informed, Matrigel-free bone-vascular organoid-like platform that integrates single-cell-guided gene programming with an osteoinductive and vascular-permissive microsphere matrix. Single-cell analysis identified BMP4 and VEGFA as key genes linking osteogenic commitment with vascular morphogenesis. Engineered BMSCs were used to sequentially generate osteoinductive bone organoid-like constructs(OLCs) and bone-vascular OLCs with coordinated osteogenic and angiogenic activity. Microfluidic GelMA/PEO/bioactive glass(BG) microsphere clusters provided adhesive, mineralization-promoting, and space-making cues for cell migration, matrix deposition, and endothelial invasion. Within seven days, the OLCs developed mineralized matrix, vascular-like sprouting, and early vascular-like microchannels. After implantation into rabbit femoral defects, they enhanced vascularized bone formation, defect bridging, and trabecular remodeling. This work demonstrates the power of development-informed, Matrigel-free bone-vascular OLCs in accelerating vascularized bone regeneration for large segmental bone defect repair.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: